药理学教学在瑞典的兽医护理学学士课程中的计划方法和实施
Lena Olsén1, Ann-Christin Blomkvist1
1Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Journal of veterinary pharmacology and therapeutics
|April 24, 2025
概括
兽医护士必需的药理学知识是复杂的. 这篇文章详细介绍了瑞典兽医护理课程中药理学教学策略,重点是课程变化和以学生为中心的学习.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 药理学教育教育 药理学教育
背景情况:
- 兽医护士需要基本的药理学知识来处理药物和药物治疗.
- 药理学在兽医护理教育和实践中是一个复杂的主题.
- 兽医护士的角色虽然在全球范围内有所不同,但不包括处方药.
研究的目的:
- 描述和讨论教学方法,教药学在瑞典的本科兽医护士.
- 在不断变化的兽医护理计划中解决药理学教育的"什么,为什么和如何".
- 为考虑修改兽医护理课程的机构提供见解.
主要方法:
- 通过预期的学习目标,教学活动和评估,介绍药理学教育的进展情况.
- 在课程中实施的学生激活教学方法的描述.
- 解释学生评价如何用于评估教育,与以学生为中心的原则保持一致.
主要成果:
- 瑞典的兽医护理课程经历了显著的增长,学生人数不断增加.
- 药理学内容,教学方法和评估的结构化进展已经实施.
- 以学生为中心的方法和评估是评估和改善教育体验的组成部分.
结论:
- 兽医护士有效的药理学教育需要仔细考虑课程设计和教学策略.
- 调整教学方法以适应课程增长和学生需求至关重要.
- 学生的评估为提高兽医护理药理学教育提供了宝贵的反.
相关概念视频
Nursing Process for Patient and Caregiver Teaching II: Planning and Implementation
1.1K
Planning for learning involves the development of a teaching plan. Teaching plans are similar to nursing care plans—both follow the steps of the nursing process. Planning in the teaching process involves setting goals and outcomes. Here, goals identify what a patient needs to achieve to understand a healthcare topic better, whereas the outcomes are the action to be performed by the patient to achieve the goal within a timeframe. For example, if the goal is to educate the patient about...
1.1K
Pharmacovigilance
739
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
739
Preclinical Development: Overview
4.0K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.0K
Model Approaches for Pharmacokinetic Data: Compartment Models
53
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
53
Drug Administration and Therapy Phases: Overview
385
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
385
Model Approaches for Pharmacokinetic Data: Physiological Models
17
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
17


